(@ellenflannery) kudos icon +

Pediatric Cancer

Public/Private Partnerships

In this exciting time of promise in cancer research, I suggest that we align the stakeholders in a collaborative effort to accelerate progress toward gentler treatments and cures for children. aPODD, a European non-profit, is an example of this.

Voting

0 votes
Ideate
(@ellenflannery) kudos icon +

Pediatric Cancer

Funding Innovative Research Ideas

The NIH/NCI have a reputation for funding "safe" research ideas - those with a high probability of success. The real breakthroughs in science come when we take big risks with the hope of big rewards. It is time.

Voting

0 votes
Ideate
(@huizong) kudos icon +

Pediatric Cancer

Associate Professor

Pediatric cancers tend to be caused by arrested development, getting stuck in a progenitor state and failing to differentiate into quiescent cells. Turning cancer cells into harmless cells with differentiation therapy should be very effective.

Voting

0 votes
Ideate
(@sami.althubaiti) kudos icon +

Pediatric Cancer

Differentiating agents

Acute promyelocytic leukemia one of successfully treated leukemia using differentiation agent , instead of killing cancer cells, to promote them to be a normal cells, we can use this strategy in treatment of other type of leukemia

Voting

0 votes
Ideate
(@nicolerozsmanmills) kudos icon +

Pediatric Cancer

DIPG Research

Currently, a DIPG diagnosis is a death sentence. There is no hope offered to families and 300-500 children die each year, and yet DIPG research is grossly underfunded. That is inexcusable.

Voting

0 votes
Ideate